GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 131 filers reported holding GENOMIC HEALTH INC in Q2 2016. The put-call ratio across all filers is 1.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,168,000 | +121.6% | 16,678 | +103.9% | 0.07% | +105.9% |
| Q4 2018 | $527,000 | -67.2% | 8,178 | -74.3% | 0.03% | -47.7% |
| Q2 2018 | $1,606,000 | +53.4% | 31,871 | -4.8% | 0.06% | +54.8% |
| Q1 2018 | $1,047,000 | +280.7% | 33,493 | +295.1% | 0.04% | +180.0% |
| Q2 2017 | $275,000 | +32.9% | 8,478 | +28.9% | 0.02% | +50.0% |
| Q1 2017 | $207,000 | -68.4% | 6,578 | -70.5% | 0.01% | -74.4% |
| Q4 2016 | $655,000 | +70.1% | 22,300 | +43.1% | 0.04% | +129.4% |
| Q1 2016 | $385,000 | -75.3% | 15,580 | -64.8% | 0.02% | -77.0% |
| Q4 2015 | $1,558,000 | +385.4% | 44,280 | +262.5% | 0.07% | +335.3% |
| Q1 2014 | $321,000 | -51.4% | 12,215 | -45.9% | 0.02% | -51.4% |
| Q4 2013 | $660,000 | +117.1% | 22,579 | +126.6% | 0.04% | +105.9% |
| Q3 2013 | $304,000 | – | 9,963 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $56,620,000 | 5.32% |
| Baker Brothers Advisors | 13,655,618 | $386,590,000 | 4.87% |
| NORTH TIDE CAPITAL, LLC | 1,500,000 | $42,465,000 | 3.24% |
| Murphy Michael R | 291,292 | $8,246,000 | 2.85% |
| Tributary Capital Management, LLC | 111,244 | $3,149,000 | 0.66% |
| Champlain Investment Partners, LLC | 1,234,780 | $34,957,000 | 0.61% |
| IRONBRIDGE CAPITAL MANAGEMENT LP | 454,085 | $12,855,000 | 0.34% |
| STONEBRIDGE CAPITAL MANAGEMENT INC | 27,180 | $769,000 | 0.30% |
| Motley Fool Asset Management LLC | 36,179 | $1,139,000 | 0.24% |
| Kimelman & Baird, LLC | 35,800 | $1,013,000 | 0.19% |